Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market Study In Greece Of A Minimally Invasive Lower Eyelid Treatment Utilizing The Renuvion System

NCT05605691 is registered in ClinicalTrials.gov with Apyx Medical as lead sponsor.

NCT NCT05605691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05605691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market Study In Greece Of A Minimally Invasive Lower Eyelid Treatment Utilizing The Renuvion System
Lead sponsor
Apyx Medical
Phase
Not applicable
Overall status
Completed
Start date
October 11, 2022
Completion date
March 5, 2024
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin laxity